Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents

被引:142
作者
Asati, Vivek [1 ]
Mahapatra, Debarshi Kar [1 ]
Bharti, Sanjay K. [1 ]
机构
[1] Guru Ghasidas Vishwavidyalaya, Inst Pharmaceut Sci, Bilaspur 495009, Chhattisgarh, India
关键词
Thiazolidine-2,4-dione; ERK; PI3K; Antiproliferative activity; Signaling pathways; Kinases; PROLIFERATOR-ACTIVATED-RECEPTOR; MEK-ERK PATHWAY; PPAR-GAMMA; BIOLOGICAL EVALUATION; GASTRIC-CANCER; CELL-GROWTH; DIFFERENTIAL EXPRESSION; PANCREATIC-CANCER; SIGNALING PATHWAY; HYBRID MOLECULES;
D O I
10.1016/j.ejmech.2014.10.025
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A variety of substituents on the thiazolidine-2,4-dione(TZD) nucleus have provided a wide spectrum of biological activities by the using of different mechanism on various target sites. PPAR gamma ligands have recently been demonstrated to affect cell proliferation, differentiation and apoptosis of different cell types. Currently, some of the TZDs are designed for the treatment of human cancers expressing high levels of PPAR gamma because it is assumed that activation of PPAR gamma mediates their anticancer activity. Another site for TZDs is survival signaling pathways under growth factor loops have been implicated in cancer development, progression, and metastasis. The Raf/MEK/ERK, Wnt and PI3K/Akt signalling cascades are the most commonly up-regulated in human cancers. In the present review, various derivatives of thiazolidine-2,4-diones its SAR and different signaling pathways involved to produce anticancer activity been highlighted. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:814 / 833
页数:20
相关论文
共 98 条
[1]
New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties [J].
Alegaon, Shankar G. ;
Alagawadi, Kallanagouda R. .
MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (06) :816-824
[2]
Selective activation of PPARγ in breast, colon, and lung cancer cell lines [J].
Allred, CD ;
Kilgore, MW .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 235 (1-2) :21-29
[3]
[Anonymous], 2013, Cancer Facts and Figures
[4]
Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents [J].
Avupati, Vasudeva Rao ;
Yejella, Rajendra Prasad ;
Akula, Annapurna ;
Guntuku, Girija Sankar ;
Doddi, Bhagya Raju ;
Vutla, Venkata Rao ;
Anagani, Suvarna Ratna ;
Adimulam, Lakshmana Santhi ;
Vyricharla, Aruna Kumar .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) :6442-6450
[5]
2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents [J].
Azizmohammadi, Mohammad ;
Khoobi, Mehdi ;
Ramazani, Ali ;
Emami, Saeed ;
Zarrin, Abdolhossein ;
Firuzi, Omidreza ;
Miri, Ramin ;
Shafiee, Abbas .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 59 :15-22
[6]
Banos F.W.A., 2013, BIOORGAN MED CHEM, V20, P3533
[7]
Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans [J].
Bar-Tana, J .
TOXICOLOGY LETTERS, 2001, 120 (1-3) :9-19
[8]
Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligands [J].
Barros, Cleiton Diniz ;
Amato, Angelica Amorim ;
de Oliveira, Tiago Bento ;
Rocha Iannini, Karime Bicas ;
da Silva, Anekecia Lauro ;
da Silva, Teresinha Goncalves ;
Leite, Elisa Soares ;
Hernandes, Marcelo Zaldini ;
Alves de Lima, Maria do Carmo ;
Galdino, Suely Lins ;
Rocha Neves, Francisco de Assis ;
Pitta, Ivan da Rocha .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (11) :3805-3811
[9]
PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer [J].
Belfiore, A. ;
Genua, M. ;
Malaguarnera, R. .
PPAR RESEARCH, 2009, 2009
[10]
The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435